Tulopafant
98%
- Product Code: 103057
CAS:
116289-53-3
| Molecular Weight: | 425.5 g./mol | Molecular Formula: | C₂₅H₁₉N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Used primarily in research settings to study its effects as a platelet-activating factor antagonist. It has been investigated for its potential therapeutic applications in managing conditions related to inflammation and thrombosis. Studies have explored its role in mitigating the adverse effects of platelet-activating factor in various inflammatory and cardiovascular disorders. However, its clinical use remains limited, and it is mainly utilized in experimental models to understand the mechanisms of platelet-activating factor in disease processes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $2,745.90 |
+
-
|
| 0.005 | 10-20 days | $5,731.00 |
+
-
|
Tulopafant
Used primarily in research settings to study its effects as a platelet-activating factor antagonist. It has been investigated for its potential therapeutic applications in managing conditions related to inflammation and thrombosis. Studies have explored its role in mitigating the adverse effects of platelet-activating factor in various inflammatory and cardiovascular disorders. However, its clinical use remains limited, and it is mainly utilized in experimental models to understand the mechanisms of platelet-activating factor in disease processes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :